039 DT-PACE Explained: When Myeloma Needs a Different Approach
This episode explains when DT-PACE chemotherapy is used in myeloma, how it works, what patients can expect during treatment, and why it remains an important bridge to newer therapies.
📌Key Takeaways:
Why use older chemotherapy? Sometimes it's the fastest way to get myeloma back under control.
DT-PACE is a bridge - helping patients reach treatments like stem cell transplant or CAR T-cell therapy.
The treatment is intensive, but careful monitoring helps manage side effects and maximise its benefits.
For extra content and more resources, please visit our website: https://www.themyelomaminutes.com/ (https://www.themyelomaminutes.com/)
We are proudly partnered with Myeloma UK for this episode. For more credible myeloma advice, please visit: https://www.myeloma.org.uk/ (https://www.myeloma.org.uk/)
The Myeloma UK InfoLine is: 0800 980 3332
This podcast is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional for personalised medical guidance regarding your health concerns
ABOUT YOUR HOSTS
Dr Jam Kothari (@myeloma_medic) is an Oxford based blood cancer doctor, specialising in the treatment of multiple myeloma and associated conditions. He has been a consultant for a decade, and leads the provision of myeloma care for Oxford and neighbouring areas. He lectures regionally and nationally and leads clinical trials investigating the use of new treatments for myeloma. He is a strong believer in patient based, holistic care, delivered with warmth, clarity and integrity.
Dr Sally Moore is a Bristol based consultant who specialises in treating patients living with multiple myeloma and other plasma cell disorders. She oversees the delivery of clinical research studies for myeloma patients and has academic interests in how to maximise quality of life for patients and improve outcomes in older, less fit patients. She frequently contributes to myeloma related educational events for fellow doctors and healthcare professionals at a local, regional and national level and is an active member of the UK Myeloma Research Alliance and an executive member of the UK Myeloma Society.
25 Jun 2026
038 A New Four-Drug Treatment for Myeloma: What Does DVRD Mean for Patients?
Experts discuss the approval of the new DVRD four-drug treatment for newly diagnosed myeloma patients who are not eligible for a stem cell transplant, exploring its benefits, risks and how treatment decisions are personalised.
📌Key Takeaways:
New four-drug treatment now available in England and Wales
Deeper remissions and longer disease control for many patients
Why the “best” treatment depends on you, not just the disease
For extra content and more resources, please visit our website: https://www.themyelomaminutes.com/ (https://www.themyelomaminutes.com/)
We are proudly partnered with Myeloma UK for this episode. For more credible myeloma advice, please visit: https://www.myeloma.org.uk/ (https://www.myeloma.org.uk/)
The Myeloma UK InfoLine is: 0800 980 3332
This podcast is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional for personalised medical guidance regarding your health concerns
ABOUT YOUR HOSTS
Dr Jam Kothari (@myeloma_medic) is an Oxford based blood cancer doctor, specialising in the treatment of multiple myeloma and associated conditions. He has been a consultant for a decade, and leads the provision of myeloma care for Oxford and neighbouring areas. He lectures regionally and nationally and leads clinical trials investigating the use of new treatments for myeloma. He is a strong believer in patient based, holistic care, delivered with warmth, clarity and integrity.
Dr Sally Moore is a Bristol based consultant who specialises in treating patients living with multiple myeloma and other plasma cell disorders. She oversees the delivery of clinical research studies for myeloma patients and has academic interests in how to maximise quality of life for patients and improve outcomes in older, less fit patients. She frequently contributes to myeloma related educational events for fellow doctors and healthcare professionals at a local, regional and national level and is an active member of the UK Myeloma Research Alliance and an executive member of the UK Myeloma Society.
11 Jun 2026
037 From Patient to Author: Jonathan Gluck’s Myeloma Story
Author Jonathan Gluck shares his deeply personal experience of living with myeloma, reflecting on diagnosis, uncertainty, treatment, resilience and what it means to build a life alongside cancer.
📌Key Takeaways:
How do you live with uncertainty? Jonathan shares the lessons myeloma taught him.
A diagnosis can change your life - but it doesn’t have to define it.
One patient’s story of resilience, perspective and finding hope in unexpected places.
Find Jonathan's book here: Amazon UK (https://www.amazon.co.uk/Exercise-Uncertainty-Memoir-Illness-Hope/dp/0593735781/ref=sr_1_1?crid=1BJMZIBULO40S&dib=eyJ2IjoiMSJ9.zHZ6optB2-VrtOofqptrd3ajULOl8Q3oS0GS1Xtf-77GjHj071QN20LucGBJIEps.5_2Cat_EFP9lmaFWv4LX_qCnBnf_e-3iwMIWb2tkr_Q&dib_tag=se&keywords=jonathan+gluck&qid=1780998960&sprefix=jonathan+gluck%2Caps%2C115&sr=8-1)
For extra content and more resources, please visit our website: https://www.themyelomaminutes.com/ (https://www.themyelomaminutes.com/)
We are proudly partnered with Myeloma UK for this episode. For more credible myeloma advice, please visit: https://www.myeloma.org.uk/ (https://www.myeloma.org.uk/)
The Myeloma UK InfoLine is: 0800 980 3332
This podcast is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional for personalised medical guidance regarding your health concerns
ABOUT YOUR HOSTS
Dr Jam Kothari (@myeloma_medic) is an Oxford based blood cancer doctor, specialising in the treatment of multiple myeloma and associated conditions. He has been a consultant for a decade, and leads the provision of myeloma care for Oxford and neighbouring areas. He lectures regionally and nationally and leads clinical trials investigating the use of new treatments for myeloma. He is a strong believer in patient based, holistic care, delivered with warmth, clarity and integrity.
Dr Sally Moore is a Bristol based consultant who specialises in treating patients living with multiple myeloma and other plasma cell disorders. She oversees the delivery of clinical research studies for myeloma patients and has academic interests in how to maximise quality of life for patients and improve outcomes in older, less fit patients. She frequently contributes to myeloma related educational events for fellow doctors and healthcare professionals at a local, regional and national level and is an active member of the UK Myeloma Research Alliance and an executive member of the UK Myeloma Society.
Who has been a guest on The Myeloma Minutes
Names identified in recent episode analyses. Showing up to five guests.
Professor Karthik Ramasamy
Dr Ceri Bygrave
Karthik Ramasamy
Ceri Bygrave
Sean Molloy
Reach and audience
Public platform figures. Ratings count people who left a rating, not total listeners.
YouTube views
448
Score snapshot 15 Sept 2025
Apple Podcasts (US)
5.0 / 5
10 ratings
Spotify
5.0 / 5
45 ratings
Podcast Authority Score: 54 / 100
A composite of feed quality, social presence, YouTube performance and engagement. Read the methodology.
Quality
61
Social presence
0
YouTube
66
Engagement
51
Contact The Myeloma Minutes
Guest appearances
Books guests
Based on episode analysis; this does not confirm that the show is currently accepting guests.
Pod Engine is an independent podcast discovery and analytics service and is not affiliated with or endorsed by this podcast. Artwork and show content belong to their owners. Full legal notice.
Explore this show Podcast research with Pod Engine
